HilleVax Statistics
Share Statistics
HilleVax has 49.81M shares outstanding. The number of shares has increased by 0.21% in one year.
| Shares Outstanding | 49.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 22.09M |
| Failed to Deliver (FTD) Shares | 2.37K |
| FTD / Avg. Volume | 1.1% |
Short Selling Information
The latest short interest is 1.30M, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 1.30M |
| Short % of Shares Out | 2.62% |
| Short % of Float | 5.9% |
| Short Ratio (days to cover) | 5.63 |
Valuation Ratios
The PE ratio is -5.27 and the forward PE ratio is -1.06.
| PE Ratio | -5.27 |
| Forward PE | -1.06 |
| PS Ratio | 0 |
| Forward PS | 41.6 |
| PB Ratio | 2.45 |
| P/FCF Ratio | -6.68 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for HilleVax Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.62, with a Debt / Equity ratio of 0.1.
| Current Ratio | 10.62 |
| Quick Ratio | 10.62 |
| Debt / Equity | 0.1 |
| Total Debt / Capitalization | 8.68 |
| Cash Flow / Debt | -3.44 |
| Interest Coverage | -55.75 |
Financial Efficiency
Return on equity (ROE) is -0.47% and return on capital (ROIC) is -42.1%.
| Return on Equity (ROE) | -0.47% |
| Return on Assets (ROA) | -0.36% |
| Return on Capital (ROIC) | -42.1% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.37M |
| Employee Count | 90 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -86.38% in the last 52 weeks. The beta is 0.77, so HilleVax 's price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | -86.38% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 6.27 |
| Relative Strength Index (RSI) | 66.1 |
| Average Volume (20 Days) | 215.90K |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.16M |
| Operating Income | -133.34M |
| Net Income | -123.57M |
| EBITDA | -132.47M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.04 |
Balance Sheet
The company has 216.68M in cash and 51.19M in debt, giving a net cash position of 165.49M.
| Cash & Cash Equivalents | 216.68M |
| Total Debt | 51.19M |
| Net Cash | 165.49M |
| Retained Earnings | -388.56M |
| Total Assets | 220.62M |
| Working Capital | 183.33M |
Cash Flow
In the last 12 months, operating cash flow was -86.78M and capital expenditures -10.75M, giving a free cash flow of -97.53M.
| Operating Cash Flow | -86.78M |
| Capital Expenditures | -10.75M |
| Free Cash Flow | -97.53M |
| FCF Per Share | -2.4 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HLVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -145.45% |
| FCF Yield | -93.69% |
Analyst Forecast
The average price target for HLVX is $2, which is -4.3% lower than the current price. The consensus rating is "Hold".
| Price Target | $2 |
| Price Target Difference | -4.3% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -2.82 |
| Piotroski F-Score | 3 |